{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:26:01Z","timestamp":1793330761097,"version":"4.5.0"},"reference-count":290,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008102","name":"University of Cincinnati","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008641","name":"CCTST","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008641","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.pharmthera.2021.108045","type":"journal-article","created":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T16:26:01Z","timestamp":1637425561000},"page":"108045","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["A review of pregnancy-induced changes in opioid pharmacokinetics, placental transfer, and fetal exposure: Towards fetomaternal physiologically-based pharmacokinetic modeling to improve the treatment of neonatal opioid withdrawal syndrome"],"prefix":"10.1016","volume":"234","author":[{"given":"Matthijs W.","family":"van Hoogdalem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott L.","family":"Wexelblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry T.","family":"Akinbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander A.","family":"Vinks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2021.108045_bb0005","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10928-020-09698-w","article-title":"Drug dosing during pregnancy-opportunities for physiologically based pharmacokinetic models","volume":"47","author":"Abduljalil","year":"2020","journal-title":"Journal of Pharmacokinetics and Pharmacodynamics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0010","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2165\/11597440-000000000-00000","article-title":"Anatomical, physiological and metabolic changes with gestational age during normal pregnancy: A database for parameters required in physiologically based pharmacokinetic modelling","volume":"51","author":"Abduljalil","year":"2012","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0015","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s40262-018-0685-y","article-title":"Fetal physiologically based pharmacokinetic models: systems information on the growth and composition of fetal organs","volume":"58","author":"Abduljalil","year":"2019","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0020","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s40262-019-00836-3","article-title":"Fetal physiologically based pharmacokinetic models: systems information on fetal blood components and binding proteins","volume":"59","author":"Abduljalil","year":"2020","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0025","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s40262-017-0618-1","article-title":"Fetal physiologically-based pharmacokinetic models: systems information on fetal biometry and gross composition","volume":"57","author":"Abduljalil","year":"2018","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0030","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s40262-020-00973-0","article-title":"Fetal physiologically based pharmacokinetic models: systems information on fetal cardiac output and its distribution to different organs during development","volume":"60","author":"Abduljalil","year":"2021","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0035","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10928-020-09711-2","article-title":"Prediction of maternal pharmacokinetics using physiologically based pharmacokinetic models: assessing the impact of the longitudinal changes in the activity of CYP1A2, CYP2D6 and CYP3A4 enzymes during pregnancy","volume":"47","author":"Abduljalil","year":"2020","journal-title":"Journal of Pharmacokinetics and Pharmacodynamics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0040","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1124\/dmd.114.058834","article-title":"Expression of hepatic drug-metabolizing cytochrome p450 enzymes and their intercorrelations: a meta-analysis","volume":"42","author":"Achour","year":"2014","journal-title":"Drug Metabolism and Disposition: The Biological Fate of Chemicals"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0045","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/bdd.1906","article-title":"Protein expression of various hepatic uridine 5\u2032-diphosphate glucuronosyltransferase (UGT) enzymes and their inter-correlations: a meta-analysis","volume":"35","author":"Achour","year":"2014","journal-title":"Biopharmaceutics and Drug Disposition"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0050","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1054\/ijoa.1999.0312","article-title":"Ex vivo perfusion of the human placental cotyledon: implications for anesthetic pharmacology","volume":"9","author":"Ala-Kokko","year":"2000","journal-title":"International Journal of Obstetric Anesthesia"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0055","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.71","article-title":"Detection of morphine-3-sulfate and morphine-6-sulfate in human urine and plasma, and formation in liver cytosol","volume":"2","author":"Andersson","year":"2014","journal-title":"Pharmacology Research & Perspectives"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0060","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3389\/fped.2019.00154","article-title":"Placental ESRRG-CYP19A1 expressions and circulating 17-beta estradiol in IUGR pregnancies","volume":"7","author":"Anelli","year":"2019","journal-title":"Frontiers in Pediatrics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0065","first-page":"1057","article-title":"Estimating fetal exposure to the P-gp substrates, corticosteroids, by PBPK modeling to inform prevention of neonatal respiratory distress syndrome","volume":"10","author":"Anoshchenko","year":"2021","journal-title":"CPT: Pharmacometrics & Systems Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0070","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1124\/dmd.120.000067","article-title":"Gestational age-dependent abundance of human placental transporters as determined by quantitative targeted proteomics","volume":"48","author":"Anoshchenko","year":"2020","journal-title":"Drug Metabolism and Disposition: The Biological Fate of Chemicals"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0075","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.placenta.2005.06.008","article-title":"MDR1 P-gp expression and activity in intact human placental tissue; upregulation by retroviral transduction","volume":"27","author":"Atkinson","year":"2006","journal-title":"Placenta"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.105068","article-title":"Using mechanistic physiologically-based pharmacokinetic models to assess prenatal drug exposure: thalidomide versus efavirenz as case studies","volume":"140","author":"Atoyebi","year":"2019","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0085","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1021\/jm960073m","article-title":"Octanol-, chloroform-, and propylene glycol dipelargonat-water partitioning of morphine-6-glucuronide and other related opiates","volume":"39","author":"Avdeef","year":"1996","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0090","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.6405","article-title":"Prenatal risk factors and perinatal and postnatal outcomes associated with maternal opioid exposure in an urban, low-income, multiethnic US population","volume":"2","author":"Azuine","year":"2019","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108521","article-title":"Precision dosing of methadone during pregnancy: A pharmacokinetics virtual clinical trials study","volume":"130","author":"Badhan","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0100","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.drugalcdep.2019.03.013","article-title":"The optimization of methadone dosing whilst treating with rifampicin: a pharmacokinetic modeling study","volume":"200","author":"Badhan","year":"2019","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0105","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000210042","article-title":"Opioid maintenance treatment during pregnancy: occurrence and severity of neonatal abstinence syndrome. A national prospective study","volume":"15","author":"Bakstad","year":"2009","journal-title":"European Addiction Research"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0110","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1210\/endo.134.2.8299591","article-title":"Dehydroepiandrosterone sulfotransferase in the developing human fetus: quantitative biochemical and immunological characterization of the hepatic, renal, and adrenal enzymes","volume":"134","author":"Barker","year":"1994","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0115","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00228-009-0645-4","article-title":"Distribution of fentanyl in the placental intervillous space and in the different maternal and fetal compartments in term pregnant women","volume":"65","author":"de Barros Duarte","year":"2009","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0120","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2016.09.095","article-title":"Dose-adjusted plasma concentrations of sublingual buprenorphine are lower during than after pregnancy","volume":"216","author":"Bastian","year":"2017","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0125","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1177\/009127007701700402","article-title":"Comparisons of the analgesic effects of oral and intramuscular oxymorphone and of intramuscular oxymorphone and morphine in patients with cancer","volume":"17","author":"Beaver","year":"1977","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0130","doi-asserted-by":"crossref","first-page":"774","DOI":"10.3389\/fphar.2018.00774","article-title":"Cytochrome P450 enzymes involved in metoprolol metabolism and use of metoprolol as a CYP2D6 phenotyping probe drug","volume":"9","author":"Berger","year":"2018","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0135","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3109\/00498254.2014.971093","article-title":"Protein binding of fentanyl and its metabolite nor-fentanyl in human plasma, albumin and \u03b1-1 acid glycoprotein","volume":"45","author":"Bista","year":"2015","journal-title":"Xenobiotica"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0140","article-title":"Placental drug transport-on-a-chip: a microengineered in vitro model of transporter-mediated drug efflux in the human placental barrier","volume":"7","author":"Blundell","year":"2018","journal-title":"Advanced Healthcare Materials"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0145","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.placenta.2003.10.017","article-title":"Norepinephrine transporter (NET), serotonin transporter (SERT), vesicular monoamine transporter (VMAT2) and organic cation transporters (OCT1, 2 and EMT) in human placenta from pre-eclamptic and normotensive pregnancies","volume":"25","author":"Bottalico","year":"2004","journal-title":"Placenta"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0150","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1472-8206.1999.tb00009.x","article-title":"The roles of P-glycoprotein and intracellular metabolism in the intestinal absorption of methadone: in vitro studies using the rat everted intestinal sac","volume":"13","author":"Bou\u00ebr","year":"1999","journal-title":"Fundamental and Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0155","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2165\/00003088-199528020-00006","article-title":"Models for placental transfer studies of drugs","volume":"28","author":"Bourget","year":"1995","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0160","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJM198002143020702","article-title":"Effects of pregnancy and contraceptive steroids on gallbladder function","volume":"302","author":"Braverman","year":"1980","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0165","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/00498258109045291","article-title":"Biliary excretion, metabolism and enterohepatic circulation of buprenorphine","volume":"11","author":"Brewster","year":"1981","journal-title":"Xenobiotica"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0170","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/cpt1974161part151","article-title":"Morphine metabolism in man","volume":"16","author":"Brunk","year":"1974","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0175","doi-asserted-by":"crossref","first-page":"16059","DOI":"10.1016\/S0021-9258(18)82357-2","article-title":"Synthetic and natural opiates interact with P-glycoprotein in multidrug-resistant cells","volume":"268","author":"Callaghan","year":"1993","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0180","first-page":"G757","article-title":"Expression of rat hepatic multidrug resistance-associated proteins and organic anion transporters in pregnancy","volume":"283","author":"Cao","year":"2002","journal-title":"American Journal of Physiology: Gastrointestinal and Liver Physiology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0185","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ajog.2014.04.040","article-title":"Drug labeling in the practice of obstetric anesthesia","volume":"212","author":"Carvalho","year":"2015","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0190","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/187231209788654117","article-title":"Glucuronidation of buprenorphine and norbuprenorphine by human liver microsomes and UDP-glucuronosyltransferases","volume":"3","author":"Chang","year":"2009","journal-title":"Drug Metabolism Letters"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2021.108045_bb0195","first-page":"S63","article-title":"Model-informed dose optimization in pregnancy","volume":"60","author":"Chaphekar","year":"2020","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0200","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/FPC.0b013e32834ff3a5","article-title":"Glucuronidation of trans-3\u2032-hydroxycotinine by UGT2B17 and UGT2B10","volume":"22","author":"Chen","year":"2012","journal-title":"Pharmacogenetics and Genomics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0205","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/tpj.2015.98","article-title":"ABCC3 genetic variants are associated with postoperative morphine-induced respiratory depression and morphine pharmacokinetics in children","volume":"17","author":"Chidambaran","year":"2017","journal-title":"Pharmacogenomics Journal"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0210","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1124\/dmd.112.046276","article-title":"Isoform-specific regulation of cytochromes P450 expression by estradiol and progesterone","volume":"41","author":"Choi","year":"2013","journal-title":"Drug Metabolism and Disposition: The Biological Fate of Chemicals"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0215","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.drugalcdep.2004.03.012","article-title":"Neonatal abstinence syndrome in methadone-exposed infants is altered by level of prenatal tobacco exposure","volume":"75","author":"Choo","year":"2004","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.comtox.2019.100111","article-title":"Placental transfer of xenobiotics in pregnancy physiologically-based pharmacokinetic models: structure and data","volume":"12","author":"Codaccioni","year":"2019","journal-title":"Computational Toxicology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0225","first-page":"1","article-title":"Human UGT2B7 catalyzes morphine glucuronidation","volume":"25","author":"Coffman","year":"1997","journal-title":"Drug Metabolism and Disposition: The Biological Fate of Chemicals"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0230","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s13318-014-0243-4","article-title":"Placental profiling of UGT1A enzyme expression and activity and interactions with preeclampsia at term","volume":"40","author":"Collier","year":"2015","journal-title":"European Journal of Drug Metabolism and Pharmacokinetics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0235","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/FTD.0b013e3181d0bd68","article-title":"Maternal buprenorphine dose, placenta buprenorphine, and metabolite concentrations and neonatal outcomes","volume":"32","author":"Concheiro","year":"2010","journal-title":"Therapeutic Drug Monitoring"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0240","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/bja\/82.6.929","article-title":"Placental transfer of fentanyl in early human pregnancy and its detection in fetal brain","volume":"82","author":"Cooper","year":"1999","journal-title":"British Journal of Anaesthesia"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0245","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1172\/JCI102397","article-title":"Metabolism of women during the reproductive cycle. XVII. Changes in electrophoretic patterns of plasma proteins throughout the cycle and following delivery","volume":"29","author":"Coryell","year":"1950","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0250","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1124\/dmd.31.9.1125","article-title":"Evaluation of 3\u2032-azido-3\u2032-deoxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes: specificity and influence of the UGT2B7*2 polymorphism","volume":"31","author":"Court","year":"2003","journal-title":"Drug Metabolism and Disposition: The Biological Fate of Chemicals"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0255","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/QAI.0b013e31823ff052","article-title":"Efavirenz pharmacokinetics during the third trimester of pregnancy and postpartum","volume":"59","author":"Cressey","year":"2012","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0260","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s40262-017-0594-5","article-title":"A physiologically based pharmacokinetic model for pregnant women to predict the pharmacokinetics of drugs metabolized via several enzymatic pathways","volume":"57","author":"Dallmann","year":"2018","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0265","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s40262-017-0539-z","article-title":"Gestation-specific changes in the anatomy and physiology of healthy pregnant women: an extended repository of model parameters for physiologically based pharmacokinetic modeling in pregnancy","volume":"56","author":"Dallmann","year":"2017","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0270","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/s40262-017-0538-0","article-title":"Physiologically based pharmacokinetic modeling of renally cleared drugs in pregnant women","volume":"56","author":"Dallmann","year":"2017","journal-title":"Clinical Pharmacokinetics"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2021.108045_bb0275","first-page":"S70","article-title":"Drug transporters expressed in the human placenta and models for studying maternal-fetal drug transfer","volume":"59","author":"Dallmann","year":"2019","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0280","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/cpt.1084","article-title":"Physiologically based pharmacokinetic modeling in pregnancy: A systematic review of published models","volume":"104","author":"Dallmann","year":"2018","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0285","first-page":"419","article-title":"Applied concepts in PBPK modeling: How to extend an Open Systems Pharmacology model to the special population of pregnant women","volume":"7","author":"Dallmann","year":"2018","journal-title":"CPT: Pharmacometrics & Systems Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0290","first-page":"1244","article-title":"Relationship between maternal methadone dosage and neonatal withdrawal","volume":"100","author":"Dashe","year":"2002","journal-title":"Obstetrics and Gynecology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0295","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/ki.1980.124","article-title":"Renal hemodynamics and tubular function normal human pregnancy","volume":"18","author":"Davison","year":"1980","journal-title":"Kidney International"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0300","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/pds.2184","article-title":"Prescription drug use during pregnancy in developed countries: a systematic review","volume":"20","author":"Daw","year":"2011","journal-title":"Pharmacoepidemiology and Drug Safety"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0305","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0002-9378(16)36202-0","article-title":"Serum protein fractionation in normal pregnancy","volume":"82","author":"De Alvarez","year":"1961","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0310","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/bcp.12815","article-title":"Prediction of human fetal pharmacokinetics using ex vivo human placenta perfusion studies and physiologically based models","volume":"81","author":"De Sousa Mendes","year":"2016","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0315","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s40262-016-0457-5","article-title":"A physiologically-based pharmacokinetic model to predict human fetal exposure for a drug metabolized by several CYP450 pathways","volume":"56","author":"De Sousa Mendes","year":"2017","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0320","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/bcp.13458","article-title":"Parenteral bilirubin in healthy volunteers: a reintroduction in translational research","volume":"84","author":"Dekker","year":"2018","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0325","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1124\/jpet.103.053199","article-title":"Aromatase is the major enzyme metabolizing buprenorphine in human placenta","volume":"306","author":"Deshmukh","year":"2003","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0330","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0028-2243(91)90167-J","article-title":"Maternal and umbilical cord concentrations of fentanyl after epidural analgesia for cesarean section","volume":"42","author":"Desprats","year":"1991","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0335","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1124\/dmd.112.047118","article-title":"Quantitative prediction of CYP2B6 induction by estradiol during pregnancy: potential explanation for increased methadone clearance during pregnancy","volume":"41","author":"Dickmann","year":"2013","journal-title":"Drug Metabolism and Disposition: The Biological Fate of Chemicals"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0340","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0022-3476(05)82214-0","article-title":"Neonatal opiate abstinence syndrome in term and preterm infants","volume":"118","author":"Doberczak","year":"1991","journal-title":"Journal of Pediatrics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0345","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/infdis\/jiu429","article-title":"Pharmacokinetics of efavirenz and treatment of HIV-1 among pregnant women with and without tuberculosis coinfection","volume":"211","author":"Dooley","year":"2015","journal-title":"Journal of Infectious Diseases"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0350","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/cpt.967","article-title":"Protein abundance of clinically relevant drug-metabolizing enzymes in the human liver and intestine: a comparative analysis in paired tissue specimens","volume":"104","author":"Drozdzik","year":"2018","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0355","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1471-0528.2008.02073.x","article-title":"Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources","volume":"116","author":"Dryden","year":"2009","journal-title":"BJOG : An International Journal of Obstetrics and Gynaecology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0360","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1124\/jpet.105.093633","article-title":"Developmental expression of aryl, estrogen, and hydroxysteroid sulfotransferases in pre- and postnatal human liver","volume":"316","author":"Duanmu","year":"2006","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0365","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/clpt.1990.37","article-title":"Binding of d-methadone, l-methadone, and dl-methadone to proteins in plasma of healthy volunteers: role of the variants of alpha 1-acid glycoprotein","volume":"47","author":"Eap","year":"1990","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0370","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s40262-020-00915-w","article-title":"Innovative approaches for pharmacology studies in pregnant and lactating women: a viewpoint and lessons from HIV","volume":"59","author":"Eke","year":"2020","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0375","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3181\/00379727-85-20791","article-title":"Excretion of carbon-14 by man after administration of morphine-N-methyl-C","volume":"85","author":"Elliott","year":"1954","journal-title":"Proceedings of the Society for Experimental Biology and Medicine"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0380","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1365-2044.1997.154-az0160.x","article-title":"Neonatal welfare and placental transfer of fentanyl and bupivacaine during ambulatory combined spinal epidural analgesia for labour","volume":"52","author":"Fernando","year":"1997","journal-title":"Anaesthesia"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0385","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s40262-013-0123-0","article-title":"Influence of gestational age and body weight on the pharmacokinetics of labetalol in pregnancy","volume":"53","author":"Fischer","year":"2014","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0390","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1055\/s-0030-1262508","article-title":"Transplacental transfer and metabolism of buprenorphine in preterm human placenta","volume":"28","author":"Fokina","year":"2011","journal-title":"American Journal of Perinatology"},{"issue":"Suppl","key":"10.1016\/j.pharmthera.2021.108045_bb0395","first-page":"67P","article-title":"The effect of 17beta-oestradiol on fluid transport in the in vitro guinea-pig gall-bladder","volume":"266","author":"France","year":"1977","journal-title":"Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0400","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1002\/cpt.1748","article-title":"Assessment of maternal and fetal dolutegravir exposure by integrating ex vivo placental perfusion data and physiologically-based pharmacokinetic modeling","volume":"107","author":"Freriksen","year":"2020","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0405","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.2217\/pgs.13.94","article-title":"OCT1 genetic variants influence the pharmacokinetics of morphine in children","volume":"14","author":"Fukuda","year":"2013","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0410","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/j.1365-2125.2012.04363.x","article-title":"A pregnancy physiologically based pharmacokinetic (p-PBPK) model for disposition of drugs metabolized by CYP1A2, CYP2D6 and CYP3A4","volume":"74","author":"Gaohua","year":"2012","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0415","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1124\/dmd.104.001388","article-title":"The contribution of fetal metabolism to the disposition of morphine","volume":"33","author":"Garland","year":"2005","journal-title":"Drug Metabolism and Disposition: The Biological Fate of Chemicals"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0420","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1124\/dmd.108.021352","article-title":"Placental transfer and fetal elimination of morphine-3-beta-glucuronide in the pregnant baboon","volume":"36","author":"Garland","year":"2008","journal-title":"Drug Metabolism and Disposition: The Biological Fate of Chemicals"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0425","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/cpt.2044","article-title":"Pharmacokinetics and drug-drug interactions of isoniazid and efavirenz in pregnant women living with HIV in high TB incidence settings: importance of genotyping","volume":"109","author":"Gausi","year":"2021","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0430","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41540-020-00157-3","article-title":"Application of physiologically based pharmacokinetic modeling for sertraline dosing recommendations in pregnancy","volume":"6","author":"George","year":"2020","journal-title":"NPJ Systems Biology and Application"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0435","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1515\/jpme.1990.18.4.305","article-title":"Transplacental transfer of morphine in man","volume":"18","author":"Gerdin","year":"1990","journal-title":"Journal of Perinatal Medicine"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0440","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1515\/jpme.1990.18.6.479","article-title":"Maternal kinetics of morphine during labour","volume":"18","author":"Gerdin","year":"1990","journal-title":"Journal of Perinatal Medicine"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0445","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/jat.1466","article-title":"Application of quantitative structure-activity relationships for modeling drug and chemical transport across the human placenta barrier: a multivariate data analysis approach","volume":"29","author":"Giaginis","year":"2009","journal-title":"Journal of Applied Toxicology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0450","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0090-9556(24)15274-9","article-title":"Inhibition of cytochrome P-450 3A (CYP3A) in human intestinal and liver microsomes: comparison of Ki values and impact of CYP3A5 expression","volume":"27","author":"Gibbs","year":"1999","journal-title":"Drug Metabolism and Disposition: The Biological Fate of Chemicals"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0455","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.placenta.2004.05.013","article-title":"P-glycoprotein expression of the human placenta during pregnancy","volume":"26","author":"Gil","year":"2005","journal-title":"Placenta"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0460","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1017\/S0965539500000486","article-title":"Amniotic fluid volume dynamics","volume":"3","author":"Gilbert","year":"1991","journal-title":"Fetal Medicine Review"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0465","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0026-895X(24)12603-X","article-title":"Regulation of the human CYP2B6 gene by the nuclear pregnane X receptor","volume":"60","author":"Goodwin","year":"2001","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0470","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/0006-2952(94)90543-6","article-title":"Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily","volume":"47","author":"Gorski","year":"1994","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0475","doi-asserted-by":"crossref","first-page":"15655","DOI":"10.1073\/pnas.232137699","article-title":"Infection of a human hepatoma cell line by hepatitis B virus","volume":"99","author":"Gripon","year":"2002","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0480","doi-asserted-by":"crossref","first-page":"A909","DOI":"10.1096\/fasebj.21.6.A909-a","article-title":"Effects of generalized and kidney specific Mrp2 (ABCC2) deficiency on renal elimination of PAH and morphine-6-glucuronide","volume":"21","author":"Grisk","year":"2007","journal-title":"FASEB Journal"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0485","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0006-2952(96)00893-3","article-title":"Possible involvement of multiple cytochrome P450S in fentanyl and sufentanil metabolism as opposed to alfentanil","volume":"53","author":"Guitton","year":"1997","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0490","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3904\/kjim.1997.12.1.16","article-title":"Gallbladder motility change in late pregnancy and after delivery","volume":"12","author":"Hahm","year":"1997","journal-title":"Korean Journal of Internal Medicine"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0495","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0006-2952(95)02184-1","article-title":"Expression of xenobiotic-metabolizing cytochrome P450 forms in human full-term placenta","volume":"51","author":"Hakkola","year":"1996","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0500","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/10408449891344173","article-title":"Xenobiotic-metabolizing cytochrome P450 enzymes in the human feto-placental unit: role in intrauterine toxicity","volume":"28","author":"Hakkola","year":"1998","journal-title":"Critical Reviews in Toxicology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0505","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0006-2952(96)00216-X","article-title":"Detection of cytochrome P450 gene expression in human placenta in first trimester of pregnancy","volume":"52","author":"Hakkola","year":"1996","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0510","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1471-0528.1983.tb08898.x","article-title":"Serum protein pattern in normal pregnancy with special reference to acute-phase reactants","volume":"90","author":"Haram","year":"1983","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0515","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.dmpk.2020.01.005","article-title":"Cellular uptake properties of lamotrigine in human placental cell lines: investigation of involvement of organic cation transporters (SLC22A1-5)","volume":"35","author":"Hasegawa","year":"2020","journal-title":"Drug Metabolism and Pharmacokinetics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0520","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.1002\/jps.21770","article-title":"Differential involvement of P-glycoprotein (ABCB1) in permeability, tissue distribution, and antinociceptive activity of methadone, buprenorphine, and diprenorphine: In vitro and in vivo evaluation","volume":"98","author":"Hassan","year":"2009","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0525","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1002\/jps.20893","article-title":"Oxycodone induces overexpression of P-glycoprotein (ABCB1) and affects paclitaxel\u2019s tissue distribution in Sprague Dawley rats","volume":"96","author":"Hassan","year":"2007","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0530","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/clpt.2008.1","article-title":"Effects of pregnancy on CYP3A and P-glycoprotein activities as measured by disposition of midazolam and digoxin: a University of Washington specialized center of research study","volume":"84","author":"Hebert","year":"2008","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0535","series-title":"Drug overdose deaths in the United States, 1999\u20132019. NCHS Data Brief, no 394","author":"Hedegaard","year":"2020"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0540","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/10629360601053893","article-title":"Structure-based modelling in reproductive toxicology: (Q)SARs for the placental barrier","volume":"18","author":"Hewitt","year":"2007","journal-title":"SAR and QSAR in Environmental Research"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0545","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1055\/s-2006-947160","article-title":"Methadone metabolism by early gestational age placentas","volume":"23","author":"Hieronymus","year":"2006","journal-title":"American Journal of Perinatology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0550","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/BF01059734","article-title":"A review of the applications of physiologically based pharmacokinetic modeling","volume":"7","author":"Himmelstein","year":"1979","journal-title":"Journal of Pharmacokinetics and Biopharmaceutics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0555","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/jama.2020.24991","article-title":"Neonatal abstinence syndrome and maternal opioid-related diagnoses in the US, 2010-2017","volume":"325","author":"Hirai","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0560","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/clpt.1985.114","article-title":"Pregnancy-induced increase in metoprolol metabolism","volume":"37","author":"H\u00f6gstedt","year":"1985","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0565","article-title":"Physiologically-based pharmacokinetic modeling to investigate the effect of maturation on buprenorphine pharmacokinetics in newborns with neonatal opioid withdrawal syndrome","author":"van Hoogdalem","year":"2021","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0570","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/17425255.2021.1837112","article-title":"Pharmacotherapy of neonatal opioid withdrawal syndrome: a review of pharmacokinetics and pharmacodynamics","volume":"17","author":"van Hoogdalem","year":"2021","journal-title":"Expert Opinion on Drug Metabolism & Toxicology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0575","doi-asserted-by":"crossref","first-page":"e540","DOI":"10.1542\/peds.2011-3212","article-title":"Neonatal drug withdrawal","volume":"129","author":"Hudak","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0580","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/j.1651-2227.2008.00838.x","article-title":"Neonatal outcome of 58 infants exposed to maternal buprenorphine in utero","volume":"97","author":"Hytinantti","year":"2008","journal-title":"Acta Paediatrica"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0585","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1248\/bpb1978.5.521","article-title":"Determination of oxycodone metabolites in urines and feces of several mammalian species","volume":"5","author":"Ishida","year":"1982","journal-title":"Journal of Pharmacobio-Dynamics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0590","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2133\/dmpk.24.53","volume":"24","author":"Jamei","year":"2009","journal-title":"Drug Metabolism and Pharmacokinetics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0595","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1300\/J069v18n04_05","article-title":"Alterations in methadone metabolism during late pregnancy","volume":"18","author":"Jarvis","year":"1999","journal-title":"Journal of Addictive Diseases"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0600","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1080\/00498250701744633","article-title":"Regulation of UDP-glucuronosyltransferase (UGT) 1A1 by progesterone and its impact on labetalol elimination","volume":"38","author":"Jeong","year":"2008","journal-title":"Xenobiotica"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0605","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0090-9556(25)07354-4","article-title":"Metoprolol metabolism via cytochrome P4502D6 in ethnic populations","volume":"24","author":"Johnson","year":"1996","journal-title":"Drug Metabolism and Disposition: The Biological Fate of Chemicals"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0610","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1124\/jpet.103.053124","article-title":"Human hepatic CYP2E1 expression during development","volume":"307","author":"Johnsrud","year":"2003","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0615","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.drugalcdep.2013.11.006","article-title":"Neonatal outcomes and their relationship to maternal buprenorphine dose during pregnancy","volume":"134","author":"Jones","year":"2014","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0620","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/cpt.37","article-title":"Physiologically based pharmacokinetic modeling in drug discovery and development: a pharmaceutical industry perspective","volume":"97","author":"Jones","year":"2015","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0625","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/clpt.2008.156","article-title":"Correlations of maternal buprenorphine dose, buprenorphine, and metabolite concentrations in meconium with neonatal outcomes","volume":"84","author":"Kacinko","year":"2008","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0630","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1111\/bcp.13368","article-title":"A physiologically based pharmacokinetic modelling approach to predict buprenorphine pharmacokinetics following intravenous and sublingual administration","volume":"83","author":"Kalluri","year":"2017","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0635","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/ADM.0000000000000633","article-title":"The ASAM national practice guideline for the treatment of opioid use disorder: 2020 focused update","volume":"14","author":"Kampman","year":"2020","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0640","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/bcp.12207","article-title":"Expansion of a PBPK model to predict disposition in pregnant women of drugs cleared via multiple CYP enzymes, including CYP2B6, CYP2C9 and CYP2C19","volume":"77","author":"Ke","year":"2014","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0645","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/003591574804100406","article-title":"Plasma protein fractions","volume":"41","author":"Kekwick","year":"1948","journal-title":"Proceedings of the Royal Society of Medicine"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0650","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1124\/dmd.113.055772","article-title":"The roles of MRP2, MRP3, OATP1B1, and OATP1B3 in conjugated hyperbilirubinemia","volume":"42","author":"Keppler","year":"2014","journal-title":"Drug Metabolism and Disposition: The Biological Fate of Chemicals"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0655","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/cpdd.326","article-title":"Current concepts in methadone metabolism and transport","volume":"6","author":"Kharasch","year":"2017","journal-title":"Clinical Pharmacology in Drug Development"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0660","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.655320","article-title":"Pregnancy-related hormones increase UGT1A1-mediated labetalol metabolism in human hepatocytes","volume":"12","author":"Khatri","year":"2021","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0665","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.xphs.2020.09.013","article-title":"Pregnancy-related hormones increase nifedipine metabolism in human hepatocytes by inducing CYP3A4 expression","volume":"110","author":"Khatri","year":"2021","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0670","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/0091-3057(75)90022-2","article-title":"Voluntary morphine ingestion, morphine dependence, and recovery from withdrawal signs","volume":"3","author":"Khavari","year":"1975","journal-title":"Pharmacology, Biochemistry and Behavior"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0675","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1124\/dmd.108.023853","article-title":"Prediction of drug clearance by glucuronidation from in vitro data: use of combined cytochrome P450 and UDP-glucuronosyltransferase cofactors in alamethicin-activated human liver microsomes","volume":"37","author":"Kilford","year":"2009","journal-title":"Drug Metabolism and Disposition: The Biological Fate of Chemicals"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0680","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0952-8180(95)00092-5","article-title":"The pharmacokinetics of oxycodone in uremic patients undergoing renal transplantation","volume":"8","author":"Kirvela","year":"1996","journal-title":"Journal of Clinical Anesthesia"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0685","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1210\/endo.130.5.1572292","article-title":"Increasing aromatase cytochrome P-450 level in human placenta during pregnancy: studied by immunohistochemistry and enzyme-linked immunosorbent assay","volume":"130","author":"Kitawaki","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0690","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.steroids.2005.03.011","article-title":"Progesterone inhibits gallbladder motility through multiple signaling pathways","volume":"70","author":"Kline","year":"2005","journal-title":"Steroids"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0695","doi-asserted-by":"crossref","first-page":"897","DOI":"10.15585\/mmwr.mm6928a1","article-title":"Vital signs: prescription opioid pain reliever use during pregnancy \u2014 34 U.S. jurisdictions, 2019","volume":"69","author":"Ko","year":"2020","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0700","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.bcp.2012.03.016","article-title":"Estradiol induces cytochrome P450 2B6 expression at high concentrations: implication in estrogen-mediated gene regulation in pregnancy","volume":"84","author":"Koh","year":"2012","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0705","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1074\/jbc.M113.526798","article-title":"Altered expression of small heterodimer partner governs cytochrome P450 (CYP) 2D6 induction during pregnancy in CYP2D6-humanized mice","volume":"289","author":"Koh","year":"2014","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0710","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1742-7843.2012.00884.x","article-title":"Intravenous oxycodone for pain relief in the first stage of labour \u2013 maternal pharmacokinetics and neonatal exposure","volume":"111","author":"Kokki","year":"2012","journal-title":"Basic & Clinical Pharmacology & Toxicology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0715","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1016\/S0024-3205(99)00503-2","article-title":"Transfer of morphine across the human placenta and its interaction with naloxone","volume":"65","author":"Kopecky","year":"1999","journal-title":"Life Sciences"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0720","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/cpt.930","article-title":"Buprenorphine in neonatal abstinence syndrome","volume":"103","author":"Kraft","year":"2018","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0725","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2165\/00003088-199121010-00005","article-title":"Fetal drug metabolism and its possible clinical implications","volume":"21","author":"Krauer","year":"1991","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0730","first-page":"67","article-title":"Biliary secretion of methadone and methadone metabolites in man","volume":"29","author":"Kreek","year":"1980","journal-title":"Research Communications in Chemical Pathology and Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0735","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3851\/IMP3283","article-title":"Efavirenz pharmacokinetics during pregnancy and infant washout","volume":"24","author":"Kreitchmann","year":"2019","journal-title":"Antiviral Therapy"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0740","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3390\/pharmaceutics11100509","article-title":"Preparation, characterization and dermal delivery of methadone","volume":"11","author":"Kung","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0745","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejps.2014.05.003","article-title":"Sulfation of opioid drugs by human cytosolic sulfotransferases: metabolic labeling study and enzymatic analysis","volume":"62","author":"Kurogi","year":"2014","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0750","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/clinchem\/43.1.235","article-title":"Detection of intrauterine illicit drug exposure by newborn drug testing","volume":"43","author":"Kwong","year":"1997","journal-title":"Clinical Chemistry"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0755","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.clpt.2006.01.009","article-title":"Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: role of circulating active metabolites","volume":"79","author":"Lalovic","year":"2006","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0760","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1124\/dmd.32.4.447","article-title":"Quantitative contribution of CYP2D6 and CYP3A to oxycodone metabolism in human liver and intestinal microsomes","volume":"32","author":"Lalovic","year":"2004","journal-title":"Drug Metabolism and Disposition: The Biological Fate of Chemicals"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0765","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1080\/00016340802428146","article-title":"Reference values for alpha1-acid glycoprotein, alpha1-antitrypsin, albumin, haptoglobin, C-reactive protein, IgA, IgG and IgM during pregnancy","volume":"87","author":"Larsson","year":"2008","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0770","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1124\/dmd.113.054072","article-title":"Effect of gestational age on mRNA and protein expression of polyspecific organic cation transporters during pregnancy","volume":"41","author":"Lee","year":"2013","journal-title":"Drug Metabolism and Disposition: The Biological Fate of Chemicals"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0775","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00007691-199310000-00014","article-title":"Determination of the serum protein binding of oxycodone and morphine using ultrafiltration","volume":"15","author":"Leow","year":"1993","journal-title":"Therapeutic Drug Monitoring"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0780","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0006-2952(99)00180-X","article-title":"P-glycoprotein-mediated transport of morphine in brain capillary endothelial cells","volume":"58","author":"Letrent","year":"1999","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0785","first-page":"15","article-title":"Nonaqueous titration of narcotics and alkaloids","volume":"5","author":"Levi","year":"1953","journal-title":"Bulletin on Narcotics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0790","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/dmd.119.088435","article-title":"Effects of pregnancy on the pharmacokinetics of metformin","volume":"48","author":"Liao","year":"2020","journal-title":"Drug Metabolism and Disposition: The Biological Fate of Chemicals"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0795","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1479-828X.2010.01168.x","article-title":"Perinatal risk factors for the neonatal abstinence syndrome in infants born to women on methadone maintenance therapy","volume":"50","author":"Liu","year":"2010","journal-title":"Australian and New Zealand Journal of Obstetrics and Gynaecology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0800","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/jcph.1515","article-title":"Physiologically based pharmacokinetic models to predict maternal pharmacokinetics and fetal exposure to emtricitabine and acyclovir","volume":"60","author":"Liu","year":"2020","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0805","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1007\/s40262-020-00897-9","article-title":"Prediction of maternal and fetal pharmacokinetics of dolutegravir and raltegravir using physiologically based pharmacokinetic modeling","volume":"59","author":"Liu","year":"2020","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0810","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s40262-020-00977-w","article-title":"Physiologically based pharmacokinetic modeling framework to predict neonatal pharmacokinetics of transplacentally acquired emtricitabine, dolutegravir, and raltegravir","volume":"60","author":"Liu","year":"2021","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0815","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.placenta.2013.05.010","article-title":"Effect of oxygen on multidrug resistance in the first trimester human placenta","volume":"34","author":"Lye","year":"2013","journal-title":"Placenta"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0820","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3748\/wjg.15.817","article-title":"Excretion of biliary compounds during intrauterine life","volume":"15","author":"Macias","year":"2009","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0825","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/ki.1989.168","article-title":"Gestational hypercalciuria causes pathological urine calcium oxalate supersaturations","volume":"36","author":"Maikranz","year":"1989","journal-title":"Kidney International"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0830","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1477-7827-7-61","article-title":"The impact of cocaine and heroin on the placental transfer of methadone","volume":"7","author":"Malek","year":"2009","journal-title":"Reproductive Biology and Endocrinology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0835","series-title":"Buprenorphine Therapy of Opiate Addiction","first-page":"125","article-title":"Case study of neonates born to mothers undergoing buprenorphine maintenance treatment","author":"Marquet","year":"2002"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0840","doi-asserted-by":"crossref","first-page":"R963","DOI":"10.1152\/ajpregu.00173.2005","article-title":"P-glycoprotein and breast cancer resistance protein expression in human placentae of various gestational ages","volume":"289","author":"Mathias","year":"2005","journal-title":"American Journal of Physiology. Regulatory, Integrative and Comparative Physiology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0845","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/clpt.1980.138","article-title":"Intravenous fentanyl kinetics","volume":"28","author":"McClain","year":"1980","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0850","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fped.2014.00009","article-title":"Obstetric pharmacokinetic dosing studies are urgently needed","volume":"2","author":"McCormack","year":"2014","journal-title":"Frontiers in Pediatrics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0855","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1007\/s11095-013-1007-6","article-title":"Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis","volume":"30","author":"McGill","year":"2013","journal-title":"Pharmaceutical Research"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0860","first-page":"4","article-title":"Plasma protein binding and distribution of fentanyl, sufentanil, alfentanil and lofentanil in blood","volume":"257","author":"Meuldermans","year":"1982","journal-title":"Archives Internationales de Pharmocodynamie et de Th\u00e9rapie"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0865","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1124\/dmd.104.003335","article-title":"Variable expression of MRP2 (ABCC2) in human placenta: influence of gestational age and cellular differentiation","volume":"33","author":"Meyer Zu Schwabedissen","year":"2005","journal-title":"Drug Metabolism and Disposition: The Biological Fate of Chemicals"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0870","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s40262-020-00861-7","article-title":"Integration of placental transfer in a fetal-maternal physiologically based pharmacokinetic model to characterize acetaminophen exposure and metabolic clearance in the fetus","volume":"59","author":"Mian","year":"2020","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0875","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.733520","article-title":"Mechanistic coupling of a novel in silico cotyledon perfusion model and a physiologically based pharmacokinetic model to predict fetal acetaminophen pharmacokinetics at delivery","volume":"9","author":"Mian","year":"2021","journal-title":"Frontiers in Pediatrics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0880","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/03602539608994011","article-title":"The disposition of morphine and its 3- and 6-glucuronide metabolites in humans and animals, and the importance of the metabolites to the pharmacological effects of morphine","volume":"28","author":"Milne","year":"1996","journal-title":"Drug Metabolism Reviews"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0885","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-2125.1986.tb02901.x","article-title":"Paracetamol metabolism in pregnancy","volume":"22","author":"Miners","year":"1986","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0890","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1177\/1535370219851109","article-title":"Placental trophoblast transfer of opioids following exposures to individual or mixtures of opioids in vitro","volume":"244","author":"Mortensen","year":"2019","journal-title":"Experimental Biology and Medicine (Maywood, N.J.)"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0895","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.clp.2016.04.001","article-title":"Fetal physiology and the transition to extrauterine life","volume":"43","author":"Morton","year":"2016","journal-title":"Clinics in Perinatology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0900","article-title":"Basic concepts in population modeling, simulation, and model-based drug development","volume":"1","author":"Mould","year":"2012","journal-title":"CPT: Pharmacometrics & Systems Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0905","article-title":"Basic concepts in population modeling, simulation, and model-based drug development-part 2: introduction to pharmacokinetic modeling methods","volume":"2","author":"Mould","year":"2013","journal-title":"CPT: Pharmacometrics & Systems Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0910","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejps.2015.08.019","article-title":"Tuning the predictive capacity of the PAMPA-BBB model","volume":"79","author":"M\u00fcller","year":"2015","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0915","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/ajcn\/76.3.614","article-title":"The pregnancy-related decrease in fasting plasma homocysteine is not explained by folic acid supplementation, hemodilution, or a decrease in albumin in a longitudinal study","volume":"76","author":"Murphy","year":"2002","journal-title":"American Journal of Clinical Nutrition"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0920","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S0090-9556(24)14935-5","article-title":"Identification and characterization of efavirenz metabolites by liquid chromatography\/mass spectrometry and high field NMR: species differences in the metabolism of efavirenz","volume":"27","author":"Mutlib","year":"1999","journal-title":"Drug Metabolism and Disposition: The Biological Fate of Chemicals"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0925","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1124\/jpet.300.1.26","article-title":"Transplacental transfer and metabolism of buprenorphine","volume":"300","author":"Nanovskaya","year":"2002","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0930","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.bcp.2005.03.030","article-title":"Role of P-glycoprotein in transplacental transfer of methadone","volume":"69","author":"Nanovskaya","year":"2005","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0935","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1080\/14767050802610328","article-title":"Effect of plasma proteins on buprenorphine transfer across dually perfused placental lobule","volume":"22","author":"Nanovskaya","year":"2009","journal-title":"The Journal of Maternal-Fetal & Neonatal Medicine"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0940","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.bcp.2004.04.011","article-title":"Methadone metabolism by human placenta","volume":"68","author":"Nanovskaya","year":"2004","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0945","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2007.06.073","article-title":"Transfer of methadone across the dually perfused preterm human placental lobule","volume":"198","author":"Nanovskaya","year":"2008","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0950","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1055\/s-2006-951301","article-title":"Role of human placental efflux transporter P-glycoprotein in the transfer of buprenorphine, levo-alpha-acetylmethadol, and paclitaxel","volume":"23","author":"Nekhayeva","year":"2006","journal-title":"American Journal of Perinatology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0955","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF00548403","article-title":"Effect of urinary pH on the disposition of methadone in man","volume":"22","author":"Nilsson","year":"1982","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0960","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1001\/jama.2020.17477","article-title":"Nonfatal opioid overdoses at an urban emergency department during the COVID-19 pandemic","volume":"324","author":"Ochalek","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0965","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000441220","article-title":"Maternal buprenorphine dose at delivery and its relationship to neonatal outcomes","volume":"22","author":"O\u2019Connor","year":"2016","journal-title":"European Addiction Research"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0970","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.2215\/CJN.00470112","article-title":"Obstetric nephrology: renal hemodynamic and metabolic physiology in normal pregnancy","volume":"7","author":"Odutayo","year":"2012","journal-title":"Clinical Journal of the American Society of Nephrology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0975","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1089\/cap.1998.8.161","article-title":"A review of developmental aspects of cytochrome P450","volume":"8","author":"Oesterheld","year":"1998","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0980","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1124\/dmd.109.031393","article-title":"Efavirenz primary and secondary metabolism in vitro and in vivo: identification of novel metabolic pathways and cytochrome P450 2A6 as the principal catalyst of efavirenz 7-hydroxylation","volume":"38","author":"Ogburn","year":"2010","journal-title":"Drug Metabolism and Disposition: The Biological Fate of Chemicals"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0985","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1124\/dmd.108.022087","article-title":"Involvement of the pyrilamine transporter, a putative organic cation transporter, in blood-brain barrier transport of oxycodone","volume":"36","author":"Okura","year":"2008","journal-title":"Drug Metabolism and Disposition: The Biological Fate of Chemicals"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0990","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1126\/science.176.4034.525","article-title":"Methadone binding to human plasma albumin","volume":"176","author":"Olsen","year":"1972","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2021.108045_bb0995","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/cpt1973143338","article-title":"Methadone binding to human plasma proteins","volume":"14","author":"Olsen","year":"1973","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1000","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/cpt197517131","article-title":"Morphine binding to human plasma proteins","volume":"17","author":"Olsen","year":"1975","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1005","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/clpt.1990.2","article-title":"Morphine and metabolite behavior after different routes of morphine administration: demonstration of the importance of the active metabolite morphine-6-glucuronide","volume":"47","author":"Osborne","year":"1990","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1010","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1365-2125.1992.tb04121.x","article-title":"The analgesic activity of morphine-6-glucuronide","volume":"34","author":"Osborne","year":"1992","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1015","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0022-3476(89)80860-1","article-title":"Drug screening of meconium in infants of drug-dependent mothers: an alternative to urine testing","volume":"115","author":"Ostrea","year":"1989","journal-title":"Journal of Pediatrics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1020","first-page":"821","article-title":"Une nouvelle technique de perfusion de l\u2019espace intervilleux dans le placenta humain isole","volume":"15","author":"Panigel","year":"1967","journal-title":"Pathologie et Biologie"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002160","article-title":"Pregnancy-associated changes in pharmacokinetics: a systematic review","volume":"13","author":"Pariente","year":"2016","journal-title":"PLoS Medicine"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1030","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/sj.clpt.6100046","article-title":"Genetic polymorphisms in the ABCB1 gene and the effects of fentanyl in Koreans","volume":"81","author":"Park","year":"2007","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1035","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0006-291X(03)00327-9","article-title":"Effects of maturation on RNA transcription and protein expression of four MRP genes in human placenta and in BeWo cells","volume":"303","author":"Pascolo","year":"2003","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1040","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1124\/dmd.120.000322","article-title":"Development and verification of a linked \u0394 (9)-THC\/11-OH-THC physiologically based pharmacokinetic model in healthy, nonpregnant population and extrapolation to pregnant women","volume":"49","author":"Patilea-Vrana","year":"2021","journal-title":"Drug Metabolism and Disposition: The Biological Fate of Chemicals"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1045","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2020-029074","article-title":"Neonatal opioid withdrawal syndrome","volume":"146","author":"Patrick","year":"2020","journal-title":"Pediatrics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1050","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1124\/dmd.105.003681","article-title":"In vitro metabolism study of buprenorphine: evidence for new metabolic pathways","volume":"33","author":"Picard","year":"2005","journal-title":"Drug Metabolism and Disposition: The Biological Fate of Chemicals"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1055","article-title":"Prediction of maternal and fetal pharmacokinetics of indomethacin in pregnancy","author":"Pillai","year":"2021","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3565(25)21130-2","article-title":"Altered methadone pharmacokinetics in methadone-maintained pregnant women","volume":"233","author":"Pond","year":"1985","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1065","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1600-0773.1994.tb01068.x","article-title":"Liposolubility and protein binding of oxycodone in vitro","volume":"74","author":"P\u00f6yhi\u00e4","year":"1994","journal-title":"Pharmacology and Toxicology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1070","series-title":"NDA: 20\u2013733 Suboxone\u00ae sublingual tablets \u2013 Clinical pharmacology\/biopharmaceutics review","author":"Reckitt & Colman Pharmaceuticals","year":"2000"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1075","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2165\/00003088-198106050-00004","article-title":"Pharmacokinetics of metoprolol in patients with hepatic cirrhosis","volume":"6","author":"Reg\u00e5rdh","year":"1981","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1080","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0016-5085(79)80141-9","article-title":"Effect of pregnancy on bile flow and biliary lipids in the hamster","volume":"76","author":"Reyes","year":"1979","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1085","first-page":"2734","article-title":"Sulfation of thyroid hormone and dopamine during human development: ontogeny of phenol sulfotransferases and arylsulfatase in liver, lung, and brain","volume":"86","author":"Richard","year":"2001","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1090","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0163-7258(99)00046-7","article-title":"Fetal hepatic drug elimination","volume":"84","author":"Ring","year":"1999","journal-title":"Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1095","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1211\/0022357022782","article-title":"Effect of P-glycoprotein inhibition on methadone analgesia and brain distribution in the rat","volume":"56","author":"Rodriguez","year":"2004","journal-title":"Journal of Pharmacy and Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1100","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF03008789","article-title":"Maternal and fetal effects of intravenous patient-controlled fentanyl analgesia during labour in a thrombocytopenic parturient","volume":"39","author":"Rosaeg","year":"1992","journal-title":"Canadian Journal of Anaesthesia"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1105","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev-pharmtox-010510-100540","article-title":"Physiologically-based pharmacokinetics in drug development and regulatory science","volume":"51","author":"Rowland","year":"2011","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1110","first-page":"33","article-title":"Drug disposition and effects in the fetus","volume":"15","author":"Rurak","year":"1991","journal-title":"Journal of Developmental Physiology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1115","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1080\/14767058.2017.1414180","article-title":"Nonpharmacological management of neonatal abstinence syndrome: a review of the literature","volume":"32","author":"Ryan","year":"2019","journal-title":"The Journal of Maternal-Fetal & Neonatal Medicine"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1120","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/jcph.631","article-title":"Pharmacokinetics of metoprolol during pregnancy and lactation","volume":"56","author":"Ryu","year":"2016","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1125","first-page":"45","article-title":"Mechanisms of CYP3A induction during pregnancy: studies in HepaRG cells","volume":"21","author":"Sachar","year":"2019","journal-title":"The American Association of Pharmaceutical Scientists Journal"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1130","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/tpj.2014.56","article-title":"Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics","volume":"15","author":"Sadhasivam","year":"2015","journal-title":"Pharmacogenomics Journal"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1135","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0169-409X(99)00004-6","article-title":"Techniques to study human placental transport","volume":"38","author":"Sastry","year":"1999","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1140","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s40262-017-0583-8","article-title":"Prediction of fetal darunavir exposure by integrating human ex-vivo placental transfer and physiologically based pharmacokinetic modeling","volume":"57","author":"Schalkwijk","year":"2018","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1145","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3389\/fphar.2019.00046","article-title":"Assessing the 2004-2018 fentanyl misusing issues reported to an international range of adverse reporting systems","volume":"10","author":"Schifano","year":"2019","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1150","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jpeds.2010.03.033","article-title":"Relationship between maternal methadone dose at delivery and neonatal abstinence syndrome","volume":"157","author":"Seligman","year":"2010","journal-title":"Journal of Pediatrics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1155","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1186\/s40064-016-2576-8","article-title":"Predictors of neonatal abstinence syndrome in buprenorphine exposed newborn: can cord blood buprenorphine metabolite levels help?","volume":"5","author":"Shah","year":"2016","journal-title":"Springerplus"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1160","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1093\/humrep\/13.8.2317","article-title":"Placental transfer of fentanyl in early human pregnancy","volume":"13","author":"Shannon","year":"1998","journal-title":"Human Reproduction"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1165","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.734122","article-title":"Mechanistic modeling of maternal lymphoid and fetal plasma antiretroviral exposure during the third trimester","volume":"9","author":"Shenkoya","year":"2021","journal-title":"Frontiers in Pediatrics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1170","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1620\/tjem.105.45","article-title":"Analgesic effect of morphine glucuronides","volume":"105","author":"Shimomura","year":"1971","journal-title":"Tohoku Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1175","doi-asserted-by":"crossref","DOI":"10.1124\/dmd.121.000612","article-title":"Predicting maternal-fetal disposition of fentanyl following intravenous and epidural administration using physiologically-based pharmacokinetic modeling","author":"Shum","year":"2021","journal-title":"Drug Metabolism and Disposition: The Biological Fate of Chemicals"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1180","article-title":"Physiologically based pharmacokinetic modelling in pregnancy: model reproducibility and external validation","author":"Silva","year":"2021","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1185","first-page":"365","article-title":"Bilirubin excretion as a test for liver function during normal pregnancy","volume":"52","author":"Soffer","year":"1933","journal-title":"Bulletin of the Johns Hopkins Hospital"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1190","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.fertnstert.2005.02.045","article-title":"Steroid hormone levels in pregnancy and 1 year postpartum using isotope dilution tandem mass spectrometry","volume":"84","author":"Soldin","year":"2005","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1195","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1124\/dmd.31.9.1086","article-title":"Isoform selectivity and kinetics of morphine 3- and 6-glucuronidation by human UDP-glucuronosyltransferases: evidence for atypical glucuronidation kinetics by UGT2B7","volume":"31","author":"Stone","year":"2003","journal-title":"Drug Metabolism and Disposition: The Biological Fate of Chemicals"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1200","doi-asserted-by":"crossref","first-page":"R1495","DOI":"10.1152\/ajpregu.2000.279.4.R1495","article-title":"Expression of members of the multidrug resistance protein family in human term placenta","volume":"279","author":"St-Pierre","year":"2000","journal-title":"American Journal of Physiology. Regulatory, Integrative and Comparative Physiology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1205","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1007\/s00204-016-1881-x","article-title":"Integrating in vitro data and physiologically based kinetic (PBK) modelling to assess the in vivo potential developmental toxicity of a series of phenols","volume":"91","author":"Strikwold","year":"2017","journal-title":"Archives of Toxicology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1210","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10928-012-9241-9","article-title":"First dose in children: physiological insights into pharmacokinetic scaling approaches and their implications in paediatric drug development","volume":"39","author":"Strougo","year":"2012","journal-title":"Journal of Pharmacokinetics and Pharmacodynamics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1215","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1471-0528.1934.tb08766.x","article-title":"The bilirubin excretion test of liver function in pregnancy","volume":"41","author":"Sullivan","year":"1934","journal-title":"BJOG: An International Journal of Obstetrics and Gynaecology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1220","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.placenta.2005.05.007","article-title":"Expression of the multidrug resistance P-glycoprotein, (ABCB1 glycoprotein) in the human placenta decreases with advancing gestation","volume":"27","author":"Sun","year":"2006","journal-title":"Placenta"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1225","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2165\/00003088-200443080-00001","article-title":"Drug transfer and metabolism by the human placenta","volume":"43","author":"Syme","year":"2004","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1230","first-page":"89","article-title":"PBPK modeling approach to predict the behavior of drugs cleared by kidney in pregnant subjects and fetus","volume":"23","author":"Szeto","year":"2021","journal-title":"The American Association of Pharmaceutical Scientists Journal"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1235","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1124\/jpet.117.245126","article-title":"Longitudinal influence of pregnancy on nicotine metabolic pathways","volume":"364","author":"Taghavi","year":"2018","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1240","first-page":"569","article-title":"Pharmacokinetics of buprenorphine hydrochloride (BN\u2022HCl) (1): absorption, distribution, metabolism and excretion after percutaneous (TSN-09: BN\u2022HCl containing tape application) or subcutaneous administration of BN\u2022HCl in rats","volume":"16","author":"Takahashi","year":"2001","journal-title":"Xenobiotic Metabolism and Disposition"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1245","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1248\/bpb.b14-00883","article-title":"Quantitative structure-activity relationship model for the fetal-maternal blood concentration ratio of chemicals in humans","volume":"38","author":"Takaku","year":"2015","journal-title":"Biological and Pharmaceutical Bulletin"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1250","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/cpt.382","article-title":"Pregnancy-related pharmacokinetic changes","volume":"100","author":"Tasnif","year":"2016","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1255","first-page":"167","article-title":"Identification of human liver cytochrome P-450 3A4 as the enzyme responsible for fentanyl and sufentanil N-dealkylation","volume":"82","author":"Tateishi","year":"1996","journal-title":"Anesthesia and Analgesia"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1260","first-page":"205","article-title":"Kinetics of distribution of substances administered to the body, I. The extravascular modes of administration","volume":"57","author":"Teorell","year":"1937","journal-title":"Archives Internationales de Pharmacodynamie et de Th\u00e9rapie"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1265","first-page":"226","article-title":"Kinetics of distribution of substances administered to the body, II. The intravascular modes of administration","volume":"57","author":"Teorell","year":"1937","journal-title":"Archives Internationales de Pharmacodynamie et de Th\u00e9rapie"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1270","doi-asserted-by":"crossref","first-page":"7735","DOI":"10.1073\/pnas.84.21.7735","article-title":"Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues","volume":"84","author":"Thiebaut","year":"1987","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1275","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1017\/S1461145709990848","article-title":"Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2)","volume":"13","author":"Tournier","year":"2010","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1280","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.2174\/138161211797440203","article-title":"Opioid transport by ATP-binding cassette transporters at the blood-brain barrier: implications for neuropsychopharmacology","volume":"17","author":"Tournier","year":"2011","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1285","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.bcp.2013.06.019","article-title":"Morphine is a substrate of the organic cation transporter OCT1 and polymorphisms in OCT1 gene affect morphine pharmacokinetics after codeine administration","volume":"86","author":"Tzvetkov","year":"2013","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1290","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1476-5381.2009.00336.x","article-title":"Drug transporters in the human blood-placental barrier","volume":"158","author":"V\u00e4h\u00e4kangas","year":"2009","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1295","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/0306-3623(95)00047-X","article-title":"Metabolism of zidovudine","volume":"26","author":"Veal","year":"1995","journal-title":"General Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1300","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.cca.2019.04.062","article-title":"Estradiol reference intervals in women during the menstrual cycle, postmenopausal women and men using an LC-MS\/MS method","volume":"495","author":"Verdonk","year":"2019","journal-title":"Clinica Chimica Acta"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1305","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107541","article-title":"Physiologically-based pharmacokinetic models for children: Starting to reach maturation?","volume":"211","author":"Verscheijden","year":"2020","journal-title":"Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1310","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/clpt.2014.43","article-title":"PBPK model describes the effects of comedication and genetic polymorphism on systemic exposure of drugs that undergo multiple clearance pathways","volume":"95","author":"Vieira","year":"2014","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1315","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrg3185","article-title":"Insights into the regulation of protein abundance from proteomic and transcriptomic analyses","volume":"13","author":"Vogel","year":"2012","journal-title":"Nature Reviews. Genetics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1320","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1001\/jama.2018.2640","article-title":"Neonatal abstinence syndrome: advances in diagnosis and treatment","volume":"319","author":"Wachman","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1325","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1001\/jamapediatrics.2018.5029","article-title":"Pharmacologic treatment for neonatal abstinence syndrome: which medication is best?","volume":"173","author":"Wachman","year":"2019","journal-title":"JAMA Pediatrics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1330","first-page":"226","article-title":"Application of physiologically based pharmacokinetic (PBPK) modeling to support dose selection: report of an FDA public workshop on PBPK","volume":"4","author":"Wagner","year":"2015","journal-title":"CPT: Pharmacometrics & Systems Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1335","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1001\/jama.2020.17694","article-title":"Analysis of drug test results before and after the US declaration of a national emergency concerning the COVID-19 outbreak","volume":"324","author":"Wainwright","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1340","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/biolre\/iox012","article-title":"Placental transporter localization and expression in the human: the importance of species, sex, and gestational age differences","volume":"96","author":"Walker","year":"2017","journal-title":"Biology of Reproduction"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1345","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1124\/jpet.103.049601","article-title":"The cytochrome P450 2B6 (CYP2B6) is the main catalyst of efavirenz primary and secondary metabolism: implication for HIV\/AIDS therapy and utility of efavirenz as a substrate marker of CYP2B6 catalytic activity","volume":"306","author":"Ward","year":"2003","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1350","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/infdis\/163.2.226","article-title":"Pharmacokinetic disposition of zidovudine during pregnancy","volume":"163","author":"Watts","year":"1991","journal-title":"Journal of Infectious Diseases"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1355","first-page":"25","article-title":"Metabolism of heroin and its pharmacologic implications","volume":"17","author":"Way","year":"1965","journal-title":"Bulletin on Narcotics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1360","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/sj.bjp.0704335","article-title":"Release of non-neuronal acetylcholine from the isolated human placenta is mediated by organic cation transporters","volume":"134","author":"Wessler","year":"2001","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1365","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1124\/mol.107.035592","article-title":"Multidrug resistance proteins 2 and 3 provide alternative routes for hepatic excretion of morphine-glucuronides","volume":"72","author":"van de Wetering","year":"2007","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1370","series-title":"Jahresbericht der Gesellschaft f\u00fcr Natur- und Heilkunde in Dresden","first-page":"32","article-title":"Discussion \u00fcber Dr. Fiedler\u2019s Vortrag","author":"Winckel","year":"1876"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1375","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00228-005-0035-5","article-title":"Changes to methadone clearance during pregnancy","volume":"61","author":"Wolff","year":"2005","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1380","article-title":"The impact of breastfeeding on health outcomes for infants diagnosed with neonatal abstinence syndrome: a review","volume":"10","author":"Wu","year":"2018","journal-title":"Cureus"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1385","first-page":"1012","article-title":"A simplified PBPK modeling approach for prediction of pharmacokinetics of four primarily renally excreted and CYP3A metabolized compounds during pregnancy","volume":"15","author":"Xia","year":"2013","journal-title":"The American Association of Pharmaceutical Scientists Journal"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1390","doi-asserted-by":"crossref","first-page":"33338","DOI":"10.1038\/srep33338","article-title":"siRNA capsulated brain-targeted nanoparticles specifically knock down OATP2B1 in mice: a mechanism for acute morphine tolerance suppression","volume":"6","author":"Yang","year":"2016","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1395","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1471-0528.1982.tb04636.x","article-title":"Gall bladder volume and serum bile acids in cholestasis of pregnancy","volume":"89","author":"Yl\u00f6stalo","year":"1982","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1400","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1477-7517-7-24","article-title":"Route of administration for illicit prescription opioids: a comparison of rural and urban drug users","volume":"7","author":"Young","year":"2010","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1405","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/cpt.1112","article-title":"Transporters in drug development: 2018 ITC recommendations for transporters of emerging clinical importance","volume":"104","author":"Zamek-Gliszczynski","year":"2018","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1410","doi-asserted-by":"crossref","first-page":"7274","DOI":"10.1073\/pnas.0502530102","article-title":"Mice lacking multidrug resistance protein 3 show altered morphine pharmacokinetics and morphine-6-glucuronide antinociception","volume":"102","author":"Zelcer","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1415","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/FTD.0000000000000724","article-title":"Pregnancy alters CYP- and UGT-mediated metabolism of buprenorphine","volume":"42","author":"Zhang","year":"2020","journal-title":"Therapeutic Drug Monitoring"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1420","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1111\/bcp.13642","article-title":"Gestational changes in buprenorphine exposure: a physiologically-based pharmacokinetic analysis","volume":"84","author":"Zhang","year":"2018","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1425","doi-asserted-by":"crossref","first-page":"8270","DOI":"10.3390\/molecules20058270","article-title":"Prediction of placental barrier permeability: a model based on partial least squares variable selection procedure","volume":"20","author":"Zhang","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1430","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1124\/dmd.114.062984","article-title":"Prediction of gestational age-dependent induction of in vivo hepatic CYP3A activity based on HepaRG cells and human hepatocytes","volume":"43","author":"Zhang","year":"2015","journal-title":"Drug Metabolism and Disposition: The Biological Fate of Chemicals"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1435","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1124\/dmd.117.075192","article-title":"Development of a novel maternal-fetal physiologically based pharmacokinetic model I: insights into factors that determine fetal drug exposure through simulations and sensitivity analyses","volume":"45","author":"Zhang","year":"2017","journal-title":"Drug Metabolism and Disposition: The Biological Fate of Chemicals"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1440","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1124\/dmd.116.073957","article-title":"Development of a novel maternal-fetal physiologically based pharmacokinetic model II: Verification of the model for passive placental permeability drugs","volume":"45","author":"Zhang","year":"2017","journal-title":"Drug Metabolism and Disposition: The Biological Fate of Chemicals"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1445","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/bcpt.12066","article-title":"Fentanyl pharmacokinetics is not dependent on hepatic uptake by organic anion-transporting polypeptide 1B1 in human beings","volume":"113","author":"Ziesenitz","year":"2013","journal-title":"Basic & Clinical Pharmacology & Toxicology"},{"key":"10.1016\/j.pharmthera.2021.108045_bb1450","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1472-8206.2009.00781.x","article-title":"The antinociceptive effect and adverse drug reactions of oxycodone in human experimental pain in relation to genetic variations in the OPRM1 and ABCB1 genes","volume":"24","author":"Zwisler","year":"2010","journal-title":"Fundamental and Clinical Pharmacology"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725821002473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725821002473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:25:33Z","timestamp":1759011933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725821002473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":290,"alternative-id":["S0163725821002473"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2021.108045","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A review of pregnancy-induced changes in opioid pharmacokinetics, placental transfer, and fetal exposure: Towards fetomaternal physiologically-based pharmacokinetic modeling to improve the treatment of neonatal opioid withdrawal syndrome","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2021.108045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108045"}}